BAX vs. IBB
BAX (Baxter International Inc.) is a stock, while IBB (iShares Nasdaq Biotechnology ETF) is Health & Biotech Equities fund tracking the NASDAQ Biotechnology Index. Over the past 10 years, BAX returned -4.50%/yr vs 6.89%/yr for IBB. Their 0.42 correlation means their historical movements had little consistent relationship.
Performance
BAX vs. IBB - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, BAX achieves a 37.03% return, which is significantly higher than IBB's 10.55% return. Over the past 10 years, BAX has underperformed IBB with an annualized return of -4.50%, while IBB has yielded a comparatively higher 6.89% annualized return.
BAX
- 1D
- -2.21%
- 1M
- 15.50%
- 6M
- 30.48%
- YTD
- 37.03%
- 1Y
- 20.15%
- 3Y*
- -14.79%
- 5Y*
- -17.84%
- 10Y*
- -4.50%
- ALL TIME*
- 8.03%
IBB
- 1D
- -1.87%
- 1M
- -4.75%
- 6M
- 8.20%
- YTD
- 10.55%
- 1Y
- 40.47%
- 3Y*
- 13.65%
- 5Y*
- 2.65%
- 10Y*
- 6.89%
- ALL TIME*
- 7.16%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
| $187.90M | $157.57M | $141.62M | |
| $252.83M | $308.82M | $278.87M |
BAX vs. IBB - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
BAX Baxter International Inc. | 37.03% | -33.28% | -22.40% | -21.91% | -39.58% | 8.48% | -2.95% | 28.40% | 2.89% | 47.30% |
IBB iShares Nasdaq Biotechnology ETF | 10.55% | 27.98% | -2.41% | 3.76% | -13.69% | 0.95% | 26.01% | 25.42% | -9.53% | 21.08% |
Correlation
The correlation between BAX and IBB is 0.33, which is low. Their historical price movements had little consistent relationship.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | 0.33 |
Correlation (3Y) Balances recent behavior with more history. | 0.39 |
Correlation (5Y) Shows whether the relationship held over a longer period. | 0.38 |
Correlation (10Y) Provides a long-term view across more market conditions. | 0.40 |
Correlation (All Time) Calculated using the full available price history since Feb 12, 2001 | 0.42 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
BAX vs. IBB — Risk / Return Rank
BAX
IBB
BAX vs. IBB - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Baxter International Inc. (BAX) and iShares Nasdaq Biotechnology ETF (IBB). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| BAX | IBB | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.51 | ||
| Sortino ratioReturn per unit of downside risk | -1.90 | ||
| Omega ratioGain probability vs. loss probability | 1.12 | 1.33 | -0.21 |
| Calmar ratioReturn relative to maximum drawdown | 0.59 | 4.25 | -3.66 |
| Martin ratioReturn relative to average drawdown | 1.07 | 12.35 | -11.28 |
Loading charts...
Drawdowns
BAX vs. IBB - Drawdown Comparison
The maximum BAX drawdown since its inception was -81.15%, which is greater than IBB's maximum drawdown of -62.85%. Use the drawdown chart below to compare losses from any high point for BAX and IBB.
Loading charts...
Drawdown Indicators
| BAX | IBB | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -81.15% | -62.85% | -18.30% |
Max Drawdown (1Y)Largest decline over 1 year | -35.94% | -9.63% | -26.31% |
Max Drawdown (3Y)Largest decline over 3 years | -62.43% | -24.85% | -37.58% |
Max Drawdown (5Y)Largest decline over 5 years | -80.61% | -39.82% | -40.79% |
Max Drawdown (10Y)Largest decline over 10 years | -81.15% | -39.82% | -41.33% |
Current DrawdownCurrent decline from peak | -68.77% | -5.96% | -62.81% |
Average DrawdownAverage peak-to-trough decline | -21.81% | -21.06% | -0.75% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 19.94% | 3.31% | +16.63% |
Volatility
BAX vs. IBB - Volatility Comparison
Baxter International Inc. (BAX) has a higher volatility of 14.54% compared to iShares Nasdaq Biotechnology ETF (IBB) at 6.14%. This indicates that BAX's price experiences larger fluctuations and is considered to be riskier than IBB based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| BAX | IBB | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 14.54% | 6.14% | +8.40% |
Volatility (6M)Calculated over the trailing 6-month period | 35.11% | 15.87% | +19.24% |
Volatility (1Y)Calculated over the trailing 1-year period | 48.55% | 20.45% | +28.10% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 34.57% | 22.12% | +12.45% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 29.69% | 23.12% | +6.57% |
Dividends
BAX vs. IBB - Dividend Comparison
BAX's dividend yield for the trailing twelve months is around 0.76%, more than IBB's 0.22% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
BAX Baxter International Inc. | 0.76% | 2.72% | 3.57% | 3.00% | 2.26% | 1.26% | 1.19% | 1.02% | 1.11% | 0.94% | 1.14% | 87.05% |
IBB iShares Nasdaq Biotechnology ETF | 0.22% | 0.23% | 0.29% | 0.26% | 0.31% | 0.21% | 0.21% | 0.33% | 0.20% | 0.30% | 0.19% | 0.03% |
Frequently Asked Questions
BAX and IBB have a correlation of 0.33, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
BAX has higher volatility (14.54%) compared to IBB (6.14%). In terms of maximum drawdown, BAX dropped -81.15% vs IBB's -62.85%.
IBB currently has the higher Sharpe Ratio (2.00 vs 0.50), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for BAX and IBB
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer